AXGT - Axovant Gene Therapies Ltd.
Previous close
2.1
2.100 100.000%
Share volume: 0
Last Updated: Thu 12 Nov 2020 10:00:01 PM CET
Biotechnology:
-0.86%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
28%
Profitability
32%
Dept financing
35%
Liquidity
15%
Performance
25%
Sector
Health Technology
Industry
Biotechnology
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-84.96%
Return on assets
-24.23%
Return on sales
0%
Return on invested capital
111.58%
Total debt ratio
54.08%
Debt ratio change over timeo
-0.18%
Current Ratio
3.38%
Quick Ratio
0%
Cash Position Ratio
3.21%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-100.34%
Return on assets
-19.74%
Return on sales
0%
Return on invested capital
127.1%
Total debt ratio
54.37%
Debt ratio change over timeo
0.11%
Current Ratio
2.53%
Quick Ratio
0%
Cash Position Ratio
2.3%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-14.67%
Return on assets
-13.84%
Return on sales
0%
Return on invested capital
337.68%
Total debt ratio
17.53%
Debt ratio change over time
-0.75%
Current Ratio
4.94%
Quick Ratio
0%
Cash Position Ratio
4.48%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-245.01%
Return on assets
-134.39%
Return on sales
0%
Return on invested capital
35.67%
Total debt ratio
-17.7%
Debt ratio change over time
-0.18%
Current Ratio
2.65%
Quick Ratio
0%
Cash Position Ratio
2.41%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AXGT | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | -84.96% | -38.69% | -11.55% | -12.25% |
| Return on assets | -24.23% | -18.71% | -9.1% | -9.49% |
| Return on sales | 0% | -4785.64% | 0% | -349.39% |
| Return on invested capital | 111.58% | 328.34% | -54.81% | -117.39% |
| Profitability | 33% | 25% | 50% | 0% |
| Total debt ratio | 54.08% | 115.92% | 25.21% | 26.21% |
| Debt ratio change over time | -0.18% | -0.17% | -1.1% | -1.45% |
| Dept financing | 12% | 50% | 5% | 6% |
| Current Ratio | 2.53% | 9.16% | 6.1% | 4.67% |
| Quick Ratio | 0% | 12.58% | 0% | 4.35% |
| Cash Position Ratio | 2.3% | 8.72% | 2.86% | 2.07% |
| Liquididy | 20% | 55% | 25% | 58% |
| Short-term ratios | AXGT | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | -100.34% | -121.38% | -14.72% | -19.25% |
| Return on assets | -19.74% | -13.34% | -11.86% | -9.76% |
| Return on sales | 0% | -264.08% | 0% | -305.87% |
| Return on invested capital | 127.1% | 262.79% | 517.6% | -49.24% |
| Profitability | 31% | 13% | 50% | 25% |
| Total debt ratio | 54.37% | 66.94% | 26.58% | 50.82% |
| Debt ratio change over time | 0.11% | -0.82% | -1.16% | -2.24% |
| Dept financing | 45% | 25% | 10% | 19% |
| Current Ratio | 2.53% | 9.16% | 6.1% | 4.67% |
| Quick Ratio | 0% | 12.58% | 0% | 4.35% |
| Cash Position Ratio | 2.3% | 8.72% | 2.86% | 2.07% |
| Liquididy | 13% | 75% | 25% | 27% |